X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2018 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare ALEMBIC LTD with Divis Laboratories - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

ALEMBIC LTD vs DIVIS LABORATORIES - Comparison Results

ALEMBIC LTD    Change

Alembic Limited, in its 99 years of existence, has evolved from being a tincture manufacturer to one of the prominent indigenous pharma companies in India. It is among the top players in the macrolides (anti-infective) and anti-microbials (animal hea... More

DIVIS LABORATORIES 
   Change

Established in the year 1990, Divi's Laboratories has been focusing on CRAMS and is an established player in the custom chemical synthesis (CCS) and API/Intermediate segment. Around 50% of Divi's revenues are derived from custom manufacturing for glo... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    ALEMBIC LTD DIVIS LABORATORIES ALEMBIC LTD/
DIVIS LABORATORIES
 
P/E (TTM) x 62.8 35.1 179.2% View Chart
P/BV x 3.5 5.7 62.5% View Chart
Dividend Yield % 0.3 0.9 36.3%  

Financials

 ALEMBIC LTD   DIVIS LABORATORIES
EQUITY SHARE DATA
    ALEMBIC LTD
Mar-16
DIVIS LABORATORIES
Mar-17
ALEMBIC LTD/
DIVIS LABORATORIES
5-Yr Chart
Click to enlarge
High Rs531,222 4.3%   
Low Rs29784 3.7%   
Sales per share (Unadj.) Rs4.7153.1 3.1%  
Earnings per share (Unadj.) Rs8.839.9 22.0%  
Cash flow per share (Unadj.) Rs9.044.6 20.2%  
Dividends per share (Unadj.) Rs0.1510.00 1.5%  
Dividend yield (eoy) %0.41.0 36.7%  
Book value per share (Unadj.) Rs27.7201.8 13.7%  
Shares outstanding (eoy) m267.03265.47 100.6%   
Bonus/Rights/Conversions ---  
Price / Sales ratio x8.76.6 132.8%   
Avg P/E ratio x4.725.1 18.6%  
P/CF ratio (eoy) x4.622.5 20.3%  
Price / Book Value ratio x1.55.0 29.8%  
Dividend payout %1.725.0 6.8%   
Avg Mkt Cap Rs m10,962266,266 4.1%   
No. of employees `000NA9.7 0.0%   
Total wages/salary Rs m2384,687 5.1%   
Avg. sales/employee Rs ThNM4,175.0-  
Avg. wages/employee Rs ThNM481.5-  
Avg. net profit/employee Rs ThNM1,089.3-  
INCOME DATA
Net Sales Rs m1,26040,643 3.1%  
Other income Rs m264749 35.2%   
Total revenues Rs m1,52441,392 3.7%   
Gross profit Rs m8314,460 0.6%  
Depreciation Rs m611,233 5.0%   
Interest Rs m023 1.3%   
Profit before tax Rs m28513,953 2.0%   
Minority Interest Rs m00-   
Prior Period Items Rs m2,0960-   
Extraordinary Inc (Exp) Rs m-320-   
Tax Rs m63,349 0.2%   
Profit after tax Rs m2,34310,604 22.1%  
Gross profit margin %6.635.6 18.5%  
Effective tax rate %2.124.0 8.9%   
Net profit margin %185.926.1 712.5%  
BALANCE SHEET DATA
Current assets Rs m1,68940,105 4.2%   
Current liabilities Rs m4866,595 7.4%   
Net working cap to sales %95.482.5 115.7%  
Current ratio x3.56.1 57.1%  
Inventory Days Days217119 183.0%  
Debtors Days Days8181 100.4%  
Net fixed assets Rs m1,62419,995 8.1%   
Share capital Rs m534531 100.6%   
"Free" reserves Rs m5,96053,043 11.2%   
Net worth Rs m7,40453,574 13.8%   
Long term debt Rs m1040-   
Total assets Rs m8,01061,585 13.0%  
Interest coverage x950.7618.4 153.7%   
Debt to equity ratio x00-  
Sales to assets ratio x0.20.7 23.8%   
Return on assets %29.317.3 169.5%  
Return on equity %31.619.8 159.9%  
Return on capital %31.326.1 119.9%  
Exports to sales %2.90-   
Imports to sales %28.925.2 114.3%   
Exports (fob) Rs m37NA-   
Imports (cif) Rs m36410,259 3.5%   
Fx inflow Rs m3735,384 0.1%   
Fx outflow Rs m36510,399 3.5%   
Net fx Rs m-32824,985 -1.3%   
CASH FLOW
From Operations Rs m34611,493 3.0%  
From Investments Rs m-48-11,372 0.4%  
From Financial Activity Rs m-301-93 323.3%  
Net Cashflow Rs m-328 -10.6%  

Share Holding

Indian Promoters % 64.0 52.0 123.1%  
Foreign collaborators % 0.0 0.0 -  
Indian inst/Mut Fund % 0.2 11.8 1.7%  
FIIs % 9.7 19.0 51.1%  
ADR/GDR % 0.0 0.0 -  
Free float % 26.1 17.2 151.7%  
Shareholders   54,701 31,796 172.0%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare ALEMBIC LTD With:   ORCHID PHARMA LTD  WYETH LTD  ABBOTT INDIA  UNICHEM LAB  CIPLA  

Compare ALEMBIC LTD With:   ACTAVIS (US)  ADCOCK INGRAM (S. Africa)  MYLAN (US)  TEVA PHARMA (Israel)  



Today's Market

Sensex Ends 262 Points Up; ONGC & Tata Steel Top Gainers(Closing)

Indian share markets ended the day on a strong note. At the closing bell, the BSE Sensex finished higher by 262 points. While, the NSE Nifty finished up by 91 points.

Related Views on News

Aster DM Healthcare (IPO)

Feb 10, 2018

Should you subscribe to the IPO of Aster DM Healthcare Ltd?

Dr Reddy's: Milestone Payment Drives Sales (Quarterly Results Update - Detailed)

Feb 9, 2018

US business was hit by pricing pressure although there was growth sequentially led by new product launches.

Lupin: US market Declines Due to Higher Base Effect of FY17 (Quarterly Results Update - Detailed)

Feb 9, 2018

Price erosion in generic US drugs continues but seems to be bottoming out.

Biocon: US Pricing Pressure Takes Toll (Quarterly Results Update - Detailed)

Feb 2, 2018

Pricing pressure in the US and costs of the Malaysian facility hit Biocon's profits in the third quarter.

Shalby Ltd. (IPO)

Dec 2, 2017

Should you subscribe to the IPO of Shalby Ltd?

More Views on News

Most Popular

My Top Five Stocks After the Karnataka Elections(The 5 Minute Wrapup)

May 16, 2018

The markets seem confused. They're neither going up nor down. What should investors do? Consider Safe Stocks. Here's the top 5 Safe Stocks in the market today.

How A Storm Destroyed Rain Industries... And a Superb Small Cap Stock I Recommend(Profit Hunter)

May 17, 2018

A mutual fund regulation could cause small cap prices to tank - If you haven't been paying attention to your small caps - now is the time to catch the opportunities that start pouring in.

Has the Indian Home Buyer Become Smarter?(Vivek Kaul's Diary)

May 17, 2018

Home loans continue to grow, despite falling sales. What explains this phenomenon?

Beware the 5th year of the Modi Regime(The Honest Truth)

May 22, 2018

2017 was a great year for the market. You were rewarded for taking excessive risk. But Ajit Dayal believes 2018 will be different. You will be rewarded for doing the opposite. Read on to know more...

Beware of Inflated Stock Market Angels(Sector Info)

May 17, 2018

The stock of Vakrangee helps us understand why it's a bad idea to chase high-flying stocks.

More

Small Investments
BIG Returns

Zero To Millions Guide 2018
Get our special report, Zero To Millions
(2018 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

ALEMBIC LTD SHARE PRICE


May 25, 2018 (Close)

TRACK ALEMBIC LTD

  • Track your investment in ALEMBIC LTD with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

ALEMBIC LTD - ORCHID PHARMA LTD COMPARISON

COMPARE ALEMBIC LTD WITH

MARKET STATS